Holen Sie sich die Stockscreener-App
0.00
100.00%
-11.13
Schlusskurs vom Vortag:
$11.13
Offen:
$0
24-Stunden-Volumen:
0
Relative Volume:
0.00
Marktkapitalisierung:
$994.04M
Einnahmen:
$20.65M
Nettoeinkommen (Verlust:
$-192.65M
KGV:
0.00
EPS:
-2.59
Netto-Cashflow:
$-134.39M
1W Leistung:
-100.00%
1M Leistung:
-100.00%
6M Leistung:
-100.00%
1J Leistung:
-100.00%
1-Tages-Spanne:
$0.00
$0.00
1-Wochen-Bereich:
$0.00
$0.00
52-Wochen-Spanne:
$0.00
$11.40
Verve Therapeutics Inc Stock (VERV) Company Profile
Firmenname
Verve Therapeutics Inc
Sektor
Branche
Telefon
(978) 501-3026
Adresse
201 BROOKLINE AVENUE, BOSTON
Vergleichen Sie VERV mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
VERV
Verve Therapeutics Inc
|
0.00 | 994.04M | 20.65M | -192.65M | -134.39M | -2.59 |
|
VRTX
Vertex Pharmaceuticals Inc
|
420.17 | 108.04B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
478.58 | 60.75B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
585.31 | 61.26B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
829.83 | 50.32B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
164.02 | 33.75B | 398.11M | -1.03B | -868.57M | -5.7032 |
Verve Therapeutics Inc Stock (VERV) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-04-15 | Hochstufung | Cantor Fitzgerald | Neutral → Overweight |
| 2024-04-08 | Eingeleitet | H.C. Wainwright | Buy |
| 2023-04-13 | Eingeleitet | Canaccord Genuity | Buy |
| 2023-02-01 | Eingeleitet | Cantor Fitzgerald | Neutral |
| 2022-12-15 | Eingeleitet | Goldman | Sell |
| 2022-10-06 | Eingeleitet | Credit Suisse | Neutral |
| 2022-08-25 | Hochstufung | Stifel | Hold → Buy |
| 2022-06-17 | Eingeleitet | BMO Capital Markets | Outperform |
| 2022-02-18 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2021-09-24 | Eingeleitet | Stifel | Hold |
| 2021-07-12 | Eingeleitet | Guggenheim | Buy |
| 2021-07-12 | Eingeleitet | JP Morgan | Neutral |
| 2021-07-12 | Eingeleitet | Jefferies | Buy |
| 2021-07-12 | Eingeleitet | William Blair | Outperform |
Alle ansehen
Verve Therapeutics Inc Aktie (VERV) Neueste Nachrichten
Sector ETF performance correlation with Verve Therapeutics Inc.Market Performance Summary & Real-Time Stock Entry Alerts - newser.com
Verve Therapeutics Inc. stock daily chart insights2025 Market WrapUp & Growth Focused Stock Reports - newser.com
Published on: 2025-10-28 01:55:22 - newser.com
Can Verve Therapeutics Inc. stock withstand economic slowdown2025 Biggest Moves & Safe Swing Trade Setups - newser.com
Technical analysis overview for Verve Therapeutics Inc. stockJuly 2025 Summary & Weekly Stock Performance Updates - newser.com
Can you recover from losses in Verve Therapeutics Inc.Quarterly Profit Summary & Smart Allocation Stock Reports - newser.com
How Verve Therapeutics Inc. stock benefits from global expansion2025 Major Catalysts & Technical Entry and Exit Tips - newser.com
Price momentum metrics for Verve Therapeutics Inc. explainedTrade Ideas & Verified Entry Point Detection - newser.com
Automated trading signals detected on Verve Therapeutics Inc.July 2025 Market Mood & Reliable Entry Point Alerts - newser.com
Is Verve Therapeutics Inc. stock a safe buy before earningsMarket Growth Summary & Stepwise Trade Execution Plans - newser.com
Will Verve Therapeutics Inc. bounce back from current supportQuarterly Profit Report & Daily Growth Stock Tips - newser.com
How to track smart money flows in Verve Therapeutics Inc.2025 Buyback Activity & Consistent Profit Focused Trading Strategies - newser.com
Published on: 2025-10-26 19:10:13 - newser.com
Published on: 2025-10-26 04:07:23 - newser.com
Finanzdaten der Verve Therapeutics Inc-Aktie (VERV)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.00%
2.88%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):